Robert A. Michael is recorded as Chairman at AbbVie Inc. (ABBV) since July 1, 2025, CEO and Board Member at AbbVie Inc. (ABBV) since July 1, 2024, COO at AbbVie Inc. (ABBV) since June 29, 2023 and CFO at AbbVie Inc. (ABBV) since December 16, 2021. AbbVie Inc. reported in an 8-K filed February 14, 2025 that Robert A. Michael was appointed Chairman, effective July 1, 2025. AbbVie Inc. reported in an 8-K filed February 20, 2024 that Robert A. Michael was appointed Class II director, effective July 1, 2024. AbbVie Inc. reported in an 8-K filed February 20, 2024 that Robert A. Michael was appointed Chief Executive Officer, effective July 1, 2024. Equibles holds 4 filed executive changes naming Robert A. Michael; each is listed under recent activity with its source filing. The proxy statement of AbbVie Inc. reports total compensation of $8,772,853 for Robert A. Michael in fiscal 2019, including a base salary of $906,865. Disclosed compensation is on record for 2 fiscal years. Robert A. Michael has spoken on 1 investor event across 1 company, most recently for AbbVie Inc. on September 15, 2026. AbbVie Inc. is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at AbbVie Inc. includes Richard A. Gonzalez (Chairman), Scott T. Reents (CFO), Dr. John M. Carethers (Board Member) and 4 others.
“On February 13, 2025, the Board of Directors (the "Board") of AbbVie Inc. (the "Company") unanimously elected Robert A. Michael to succeed Richard A. Gonzalez as the Company's Chairman, effective July 1, 2025.”
AbbVie Inc. Form 8-K, filed February 14, 2025
· Read the filing
“The Board also appointed Mr. Michael as a member of the Board of Directors as a Class II director, effective July 1, 2024.”
AbbVie Inc. Form 8-K, filed February 20, 2024
· Read the filing
Robert A. Michael on recent calls
“So I think this one, Rupa and I will tag team. But I'm very excited about the state of the Abbey pipeline as I sit here today. You know, now we're a couple years into our next chapter.”
